• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Pace Ventures: Investment Portfolio & Startup News

Pace Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicinesTernary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
    Ternary Therapeutics
    16 Mar 2026

    Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines

    Ternary Therapeutics develops computational and laboratory tools to design molecular glue medicines. Its platform predicts how proteins interact and suggests molecules that can bring them together, helping researchers target disease-driving proteins previously considered undruggable.

    Bitfount raises £6m Series A led by Parkwalk to scale privacy-preserving AI for clinical trialsBitfount raises £6m Series A led by Parkwalk to scale privacy-preserving AI for clinical trials
    Bitfount
    23 Jul 2025

    Bitfount raises £6m Series A led by Parkwalk to scale privacy-preserving AI for clinical trials

    Bitfount provides federated AI infrastructure for clinical research, allowing hospitals and pharmaceutical companies to collaborate on trials and analysis without sharing sensitive patient data.

Pace Ventures
    • Life Sciences
  • 1(12 months)
  • paceventures.com
  • Update Information

More venture news

  • Machenta raises a £30m seed round led by Creandum and Union Square Ventures to teach robots new tasks from a single demonstration
    Machenta
    27 Oct 2026

    Machenta raises a £30m seed round led by Creandum and Union Square Ventures to teach robots new tasks from a single demonstration

    SeedDeep Tech
  • Lette secures a £5m seed round led by Peak to run leasing and resident service for rental operators
    Lette
    27 Oct 2026

    Lette secures a £5m seed round led by Peak to run leasing and resident service for rental operators

    SeedProperty
  • imphatec raises a £1.5m seed round led by SynBioVen to develop customisable-dose implants for chronic conditions
    imphatec
    26 Oct 2026

    imphatec raises a £1.5m seed round led by SynBioVen to develop customisable-dose implants for chronic conditions

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn